BioWorld Asia

Sep. 1, 2004

Potent New Oncogene Prevents Apoptosis, Turns Cells Malignant

Biovitrum Acquires Axelar's Oncology Project For IGF-1R

UCB Pharma To Close Research Sites In U.S. In Favor Of Europe

Other News To Note

NicOx Forms $37M Agreement With Pfizer In Undisclosed Area

PARIS - NicOx SA and Pfizer Inc. formed a deal in a specific, but undisclosed, field covering a selection of nitric oxide-donating compounds patented by NicOx. (BioWorld International) Read More

BioAlliance Pharma Raises EUR12M In Series C Financing

Today's news in brief

BioWorld

BioWorld briefs for March 13, 2026.

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 10, 2026

MSD synthesizes α-synuclein PET agents

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

BioWorld Science

Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...